Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers
In a 2-part study in healthy volunteers, we first established a maximally tolerated multiple dose of LY545694 of 25mg twice daily and subsequently demonstrated antihyperalgesic effect using effects in the brief thermal stimulation experimental pain model. The antihyperalgesic effect was similar to t...
Saved in:
Published in | Pain (Amsterdam) Vol. 155; no. 5; pp. 929 - 936 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Elsevier B.V
01.05.2014
International Association for the Study of Pain Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!